We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.83%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$40.5B
AUM Growth
+$7.82B
(+24%)
Cap. Flow
+$9.9B
Cap. Flow
% of AUM
24.45%
Top 10 Holdings %
Top 10 Hldgs %
11.2%
Holding
4,410
New
905
Increased
1,516
Reduced
1,218
Closed
685
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$184M |
| 2 |
Dollar General
DG
|
+$152M |
| 3 |
MongoDB
MDB
|
+$129M |
| 4 |
Starbucks
SBUX
|
+$126M |
| 5 |
Costco
COST
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$111M |
| 2 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$97.7M |
| 3 |
Automatic Data Processing
ADP
|
+$90.7M |
| 4 |
Phillips 66
PSX
|
+$82.6M |
| 5 |
CVS Health
CVS
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 5.7% |
| 4 | Healthcare | 5.63% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
PUT
JetBlue
JBLU
$1.96B
| $53.8K | ﹤0.01% |
11,700
| – | – |
|
3627
Achieve Life Sciences
ACHV
$626M
| $53.6K | ﹤0.01% |
12,474
-9,498
| -43% | -$47.9K |
|
|
THRX
3628
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $52.9K | ﹤0.01% |
+19,653
| New | +$77K |
|
|
GMDA
3629
CALL
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $51.5K | ﹤0.01% |
+50,000
| New | +$63.9K |
|
|
OMIC
3630
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $51.1K | ﹤0.01% |
4,473
-201
| -4% | -$3.73K |
|
3631
Retractable Technologies
RVP
$20.4M
| $50.5K | ﹤0.01% |
42,410
+20,471
| +93% | +$24.1K |
|
|
CGC
3632
Canopy Growth
CGC
$375M
| $49.3K | ﹤0.01% |
6,298
+978
| +18% | +$5.98K |
|
3633
Upexi
UPXI
$58.8M
| $48.8K | ﹤0.01% |
1,410
+624
| +79% | +$23.8K |
|
3634
Passage Bio
PASG
$15.9M
| $48.7K | ﹤0.01% |
3,702
+216
| +6% | +$3.55K |
|
3635
Beyond Air
XAIR
$3.72M
| $48.7K | ﹤0.01% |
+53
| New | +$69.6K |
|
3636
Outdoor Holding Co
POWW
$239M
| $47.9K | ﹤0.01% |
+23,714
| New | +$49.8K |
|
|
EXK
3637
Endeavour Silver
EXK
$2.32B
| $47.2K | ﹤0.01% |
+19,427
| New | +$57.3K |
|
3638
ReTo Eco-Solutions
RETO
$23.2M
| $47.2K | ﹤0.01% |
+42
| New | +$162K |
|
3639
Harvard Bioscience
HBIO
$27.1M
| $46.2K | ﹤0.01% |
+1,074
| New | +$49.6K |
|
3640
P3 Health Partners
PIII
$32M
| $46K | ﹤0.01% |
+626
| New | +$65K |
|
|
TDAY
3641
USA Today Co
TDAY
$1.23B
| $45.9K | ﹤0.01% |
+18,722
| New | +$51.7K |
|
3642
Karyopharm Therapeutics
KPTI
$168M
| $45.8K | ﹤0.01% |
+2,277
| New | +$51.1K |
|
3643
Organogenesis Holdings
ORGO
$308M
| $44.9K | ﹤0.01% |
14,132
-78,968
| -85% | -$251K |
|
3644
Skillsoft
SKIL
$56.9M
| $44.9K | ﹤0.01% |
+2,533
| New | +$64.2K |
|
3645
Pyxis Oncology
PYXS
$165M
| $44.9K | ﹤0.01% |
+22,556
| New | +$52.3K |
|
3646
Anixa Biosciences
ANIX
$126M
| $44.2K | ﹤0.01% |
+13,514
| New | +$47.3K |
|
3647
Cue Biopharma
CUE
$135M
| $43.5K | ﹤0.01% |
+630
| New | +$61.5K |
|
|
BTM
3648
DELISTED
Bitcoin Depot
BTM
| $43.5K | ﹤0.01% |
+2,361
| New | +$52.2K |
|
|
VNET
3649
VNET Group
VNET
$2.05B
| $42.4K | ﹤0.01% |
13,558
+3,531
| +35% | +$10.6K |
|
3650
Broadwind
BWEN
$113M
| $42.2K | ﹤0.01% |
+13,186
| New | +$50.1K |
|
Similar funds
Squarepoint's Q3 2023 Portfolio in Review
As of Q3 2023, Squarepoint held 4,410 positions worth $40.5B, up 24% from $32.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $9.9B of net new capital in Q3 2023, opening 905 new positions and adding to 1,516 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Adobe, an estimated $111M trimmed.
- Squarepoint's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
- Squarepoint added most to Tesla in Q3 2023, an estimated $184M increase.
- Squarepoint's biggest Q3 2023 reduction was Adobe, cutting an estimated $111M.
- Squarepoint fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2023, selling an estimated $56.4M.
- Squarepoint's ten largest holdings make up 11% of its $40.5B portfolio in Q3 2023.
- Squarepoint opened 905 new positions and closed 685 in Q3 2023.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $40.5B.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.